Company news, research breakthroughs, and major announcements across industries.

Home/Science

Science

AN2 Therapeutics to Participate at Upcoming Investor Conferences

AN2_Therapeutics_Press_Release_Logo.jpg
AN2_Therapeutics_Press_Release_Logo.jpg

AN2 Therapeutics, Inc. (NASDAQ: ANTX), a clinical stage biopharmaceutical company discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today announced company management will participate in three upcoming investor conferences in November. Details of the events are as follows: Guggenheim 3rd Annual Healthcare Innovation Conference, November 9-11, 2026 Eric Easom, Co-Founder, Chairman, President and CEO, will...

  • PublishedOctober 20, 2026 · 4:13 PM
  • LocationMENLO PARK, Calif.
  • IndustryScience
  • LanguageEN

Published by Business Wire. Read the original announcement for the full release.

Read the full announcement →

Latest from leading organizations

Explore recent announcements by organization